Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989–2018

Lina van der Straten(Erasmus MC), Avinash G. Dinmohamed(Netherlands Comprehensive Cancer Organisation), Eduardus F. M. Posthuma(Leiden University Medical Center), Carolien C. H. M. Maas(Erasmus University Rotterdam), Otto Visser(Netherlands Comprehensive Cancer Organisation), Arnon P. Kater(Amsterdam University Medical Centers), Mark‐David Levin(Albert Schweitzer Hospital), Anton W. Langerak(Erasmus MC), Jeanette K. Doorduijn(Erasmus MC Cancer Institute)
Blood Cancer Journal
April 20, 2022
10.1038/s41408-022-00669-7
Cited by 12

Related Papers

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
|Leukemia|2003|3k
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2018|907
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
|Journal of Clinical Oncology|2021|630
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|568
Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis
|Journal of Clinical Oncology|2010|478